Articles nAture methods | VOL.13 NO.9 | SEPTEMBER 2016 | 763 Far-red fluorescent proteins (FPs) are desirable for in vivo imaging because with these molecules less light is scattered, absorbed, or re-emitted by endogenous biomolecules compared with cyan, green, yellow, and orange FPs. We developed a new class of FP from an allophycocyanin a-subunit (APc). native APc requires a lyase to incorporate phycocyanobilin. the evolved FP, which we named small ultra-red FP (smurFP), covalently attaches a biliverdin (BV) chromophore without a lyase, and has 642/670-nm excitation-emission peaks, a large extinction coefficient (180,000 m −1 cm −1 ) and quantum yield (18%), and photostability comparable to that of eGFP. smurFP has significantly greater BV incorporation rate and protein stability than the bacteriophytochrome (BPh) FPs. moreover, BV supply is limited by membrane permeability, and smurFPs (but not BPh FPs) can incorporate a more membrane-permeant BV analog, making smurFP fluorescence comparable to that of FPs from jellyfish or coral. A far-red and near-infrared fluorescent cell cycle indicator was created with smurFP and a BPh FP.
red-shifted both excitation and emission by ~49 nm ( Supplementary Table 1 ) relative to R3-2 + PCB, illustrating the malleability of wavelengths. R4-1 and R5-2 had QYs of 9.0% and 5.3% and ECs of 93,000 and 71,000, respectively, showing diminished QY with red-shifted fluorescence.
At round 6, the selection was altered to create blue-shifted APCαFPs + BV, and 5-10 bright colonies per plate were selected, mixed, grown in lysogeny broth (LB), and the mixture of DNA was purified and retransformed to evolve FPs that grew faster in E. coli. R6-6 was selected with 650-nm excitation to blue-shifted fluorescence. R6-6 had two mutations, F36L and D73G, and had a QY of 9.6% and EC of 190,000; these values were improved relative to R5-2. R7-7 contained three mutations (E18K, R33H, and M131I). R8-8 and R8-9 contained three mutations (E48D, G96A, and K118N; and K9N, H33R, and G96D, respectively). E48D and G96A/D are located near BV, while K9N, H33R, and K118N alter surface charge. R8-8 and R8-9 had QYs of 13% and 12% and ECs of 260,000 and 175,000, respectively, which should have been less fluorescent than R7-7 (QY of 16%, EC of 250,000). R7-7, R8-8, and R8-9 were, respectively, 1.3-, 5.8-, and 5.7-fold brighter than R4-1 ( Supplementary Fig. 2c ). Clearly, fluorescence brightness is not strictly limited to QY × EC and is dependent on protein production and stability, which differ despite having the same E. coli, arabinose, plasmid, promoter, amino acid length, number of bacteria (OD 600 ), media, propagation temperature, and growth time. Round 9 FPs were not brighter than round 8 FPs, so 20 clones were randomly mutagenized. R10-10 was 8.3-fold brighter than R4-1 and contained S15T, R33H, and G96A mutations. R10-10 had a QY of 15% and an EC of 200,000, which were comparable to R7-7 (QY of 16% and EC of 250,000), but R10-10 and R7-7 were 8.3-and 1.3-fold, respectively, brighter than R4-1 ( Supplementary Fig. 2d ). R11-2 was slightly more fluorescent than R10-10 ( Supplementary Fig. 2e ) but showed no improvement in biophysical properties. R10-10 and the round 11 library were mutated for the twelfth, final selection, yielding smURFP with two mutations,Y59F and G82S, and C4S-removed disulfide bond formation. APCαFPs are aligned in Supplementary Figure 2f . smURFP is ~650-fold brighter than R1 + PCB. BV (QY of 0.013%) shows extremely weak fluorescence, but after covalent attachment to smURFP (QY of 18%), the QY is increased ~1,400-fold because of BV rigidification and has spectral properties similar to Cy5 ( Fig. 2a,b ; full absorbance in Supplementary Fig. 3a ).
characterization of smurFP and tandem dimer smurFP smURFP was compared to BPH FPs with identical growth conditions in E. coli. Fluorescence of smURFP is greater than that of infrared FPs IFP1.4 and iRFP713 (Fig. 2c) . Mass spectrometry (MS) revealed that BV attachment to APCαFPs and smURFPs is limited, and the predominant fluorescent species has one BV ( Supplementary Fig. 3) .
smURFP ran as a 32-kD homodimer on a native gel. R10-10 ran as a 32-kD homodimer, while R4-1 was a tetramer ( Supplementary  Fig. 4a ). Tandem dimer smURFP (TDsmURFP) was created by adding a 23-amino-acid linker between subunits and had ~70% fluorescence of smURFP in bacteria ( Fig. 2c) . TDsmURFP (33 kD) ran near smURFP. tdTomato (54 kD) and IFP1.4 (37 kD) confirmed the dimeric nature of smURFP ( Supplementary  Fig. 4a,b) . To confirm covalent BV attachment, the FPs were run on a denaturing gel, and BV was detected with zinc 25 . IFP1.4, smURFP, and TDsmURFP showed correct molecular weight (MW), with BV covalently attached (Supplementary Fig. 4c ). C52 is evolutionarily conserved among all APCαs and covalently attaches PCB (Supplementary Figs. 1 and 5a) . The C52S mutation eliminated smURFP fluorescence (Supplementary Fig. 5b,c) , and C52 remains the BV attachment site. The large EC of smURFP, 180,000 M −1 cm −1 per BV chromophore, and its relatively large QY of 18% make smURFP biophysically as bright as eGFP. BPH FPs have low QYs and are dimmer than smURFPs ( Table 1) .
MS showed that APCαFPs contain <1 BV per dimer when expressed with HO-1 in bacteria ( Supplementary Fig. 3) . BV incorporation rate was measured in order to determine whether this was due to lack of BV and/or to smURFP's affinity for BV. smURFP fluorescence requires BV binding and covalent attachment. 0.5 µM smURFP (1 µM empty chromophore sites) was mixed with 0.1, 1, or 10 µM BV (Supplementary Fig. 6 ). Fluorescence approached its asymptotic level as an exponential growth in time with a half-life ~39 min, independent of BV concentration, consistent with smURFP + BV forming a nonfluorescent high-affinity complex before development of fluorescence and covalent attachment to BV. Two-step kinetics are typical for phycobiliproteins and phytochromes 26, 27 . Increasing pH increases C52 nucleophilicity and the rate of fluorescence development ( Supplementary  Table 2 ). The low stoichiometry of BV relative to smURFP reflected limiting levels of BV during protein expression.
smurFP expression in neurons smURFP fluorescence was compared to that of the coralderived red FP mCherry, because fluorescence is spectrally separate from smURFP. Lentivirus was created with smURFP-T2A-mCherry, where T2A is a self-cleaving peptide sequence that ensures production of both FPs at a similar rate. Neuronal culture showed colocalized expression of both FPs. mCherry showed lysosomal aggregation 28 , which is not seen with smURFP ( Supplementary Fig. 7 ).
increasing chromophore within mammalian cells smURFP is better expressed than BPH FPs in bacteria ( Fig. 2c) .
To test whether this was the case in mammalian cells, we expressed our constructs in HEK293A cells. smURFP and TDsmURFP fluorescence is less than that of eGFP in HEK293A cells. We hypothesized that BV has low membrane permeability. 3 h of 25 µM BV addition increased smURFP and TDsmURFP fluorescence by 4.7-and 6.7-fold, respectively ( Fig. 3a) . Purification of FP + BV in E. coli requires HO-1 to produce BV, and expression of HO-1 in mammalian cells should increase BV concentration. The production of heme is highly orchestrated ( Supplementary  Fig. 8a ). Expression of cyanobacterial HO-1 with smURFP and TDsmURFP significantly increased fluorescence 2.8-and 2.0fold, respectively. The expression of HO-1 with 5-aminolevulinic acid (5-ALA, a precursor of heme) and iron(ii) sulfate (to reduce the accumulation of fluorescent protoporphyrin IX (PpIX)) showed significant increases in smURFP and TDsmURFP fluorescence of 7.7-and 7.0-fold, respectively ( Fig. 3a) . To prove that the benefit of extra BV is not limited to smURFP, we expressed HO-1 with BPH FPs. IFP1.4, IFP2.0, and iRFP713 all showed significant increases in fluorescence of 7.1-, 8.2-, and 5.7-fold, respectively, with HO-1 + 5-ALA + FeSO 4 , even though it was reported that iRFP713 does not require exogenous BV 16 (Fig. 3b) .
The more hydrophobic biliverdin dimethylester (BVMe 2 , Fig. 1c ) should have greater membrane permeability. The carboxylic acids of BV are recognition motifs and must be free for BPHs, while carboxylic groups of BV are exposed on smURFP and tolerate esterification ( Fig. 3c,d) . Addition of 25 µM BV for 3 h significantly increased fluorescence of BPH FPs ( Fig. 3e and Supplementary Fig. 9 ). Addition of 25 µM BVMe 2 or PCB (for 3 h in each case) greatly increased smURFP fluorescence-by 18-and 10-fold, respectively-relative to 25 µM BV ( Fig. 3e) . TDsmURFP was brightened by 4.0-and 5.8-fold with BVMe 2 and PCB, respectively. 25 µM PCB added to IFP2.0 blue shifted and decreased fluorescence. IFP2.0 + 25 µM BVMe 2 resulted in no fluorescence increase ( Supplementary Fig. 10 ), indicating that esterases do not remove methyl groups on BVMe 2 to form BV, which would enhance the fluorescence of IFP2.0. smURFP + BVMe 2 is ≥7-fold brighter than IFP2.0 or iRFP713 (Fig. 3e) .
The concentration dependence of different chromophores was also analyzed ( Supplementary Fig. 11 ). PCB requires ≥40 µM for fluorescence similar to 2.5 µM BVMe 2 . BVMe 2 penetrates the membrane best, reaching saturation at ≤2.5 µM. We expressed eGFP from an internal ribosomal entry site (IRES) along with smURFP expressed from the CMV promoter in the presence of BVMe 2 . Under these conditions, eGFP expression was lower relative to smURFP, and smURFP had five-fold greater fluorescence. Based on photophysical properties, smURFP is as bright as eGFP and could be equally bright in mammalian cells with sufficient chromophore in the cytoplasm.
BV contains two anionic carboxylates. Acidification protonates the carboxylates and increases BV permeability. 25 µM BV added at pH 6.4 for 3.5 h increased fluorescence three-fold relative to BV at pH 7.5. As controls, BVMe 2 incorporation or eGFP expression were not affected by a drop in extracellular pH from 7.5 to 6.4 over 3.5 h, showing no change in protein stability, protein translation, and cell health. Protonation of BV increased membrane permeability, but fluorescence was five-fold less than that of BVMe 2 . smurFP and tdsmurFP with different chromophores smURFP and TDsmURFP have two chromophore sites, but the predominant species contains only 1 BV. smURFP and TDsmURFP were expressed without HO-1 and purified without chromophore, then chromophores were added in vitro. Samples were verified with MS ( Supplementary Fig. 12 ), and biophysical properties were measured. For BV and PCB, two chromophores could attach, but the second chromophore partially quenched fluorescence and reduced the QY ( Supplementary Table 3 ). Two PCBs had a 40-nm red-shifted fluorescence ( Supplementary  Fig. 13g,i) . A single BVMe 2 bound to smURFP, while two BVMe 2 bound to TDsmURFP (Supplementary Fig. 12f,l) . For BVMe 2 , the QY of 12% remained constant. smURFP or TDsmURFP + BVMe 2 have the brightest fluorescence, not only because BVMe 2 is freely membrane permeant, but because the fluorescence is not quenched by excess chromophore.
smurFP in vivo
In order to test smURFP performance in vivo, HT1080 cells were transduced with lentivirus (≥99% efficiency) to express smURFP and mCherry ( Supplementary Fig. 14a ). smURFP and mCherry fluorescence in the HT1080 cells in vitro were equivalent when the cells were incubated in 12.5 µM BV for 3 h ( Supplementary  Fig. 14b ). HT1080 cells stably expressing smURFP and mCherry were injected into four mice bearing two tumor xenografts. smURFP fluorescence was visible without exogenous BV ( Fig. 4a) , but fluorescence intensity was 35% of that of mCherry npg ( Supplementary Fig. 14c,d) . 250 nmol BV was injected intravenously, but no fluorescence increase was seen after 2 h. Fluorescence of mCherry was greatly attenuated through the skin with a loss of 74%, while smURFP had a loss of only 25%, illustrating the importance of using FR and NIR FPs for deep-tissue imaging (Supplementary Fig. 14e ). smURFP was compared to mCardinal 29 in smaller tumors in an area with less blood flow ( Supplementary Fig. 15 ). HT1080 cells were transduced with lentivirus expressing smURFP or mCardinal (≥95% efficiency) ( Supplementary Fig. 15a ). The FPs were separated because of significant spectral overlap. smURFP is 2-to 4-fold brighter than mCardinal when BVMe 2 is added for 2 d (Supplementary Fig. 15c-e ), but smURFP is much dimmer than mCardinal in vivo (~7.3-fold at 607 nm and ~4-fold at 640 nm, Supplementary Fig. 15f ). Injection of 250 nmol BV or BVMe 2 gives no increase in fluorescence in vivo, though 10 µM BV or BVMe 2 added to excised tumors enhanced fluorescence and verified smURFP expression ( Supplementary Fig. 15g ). 10 µM BV or BVMe 2 added to plasma showed rapid removal of ester groups and slower degradation of impermeant BV ( Supplementary  Fig. 16 ), which explained the discrepancy.
FP stability
FP stability influences expression and fluorescence intensity. eGFP has a protein stability half-life (t 50% ) of ~24 h 30 , while BPH FPs have t 50% of ~4.4 h ( Table 1) . The fluorescence of smURFP in HEK293 cells continuously exposed to BV or BVMe 2 , but with protein synthesis halted by cycloheximide, declined with t 50% = 33 or 35 h, respectively ( Supplementary Fig. 17a,b) . Shortening exposure of BV or BVMe 2 to 3 h produced little difference (t 50% = 30 h and 33 h, respectively) ( Supplementary Fig. 17c,d) .
The lifetime of smURFP lacking chromophore was determined by addition of cycloheximide for various time periods, and BVMe 2 was added for 1 h. Apoprotein decayed with t 50% = 17 h ( Supplementary Fig. 17e) , showing a modest destabilization. As a control, eGFP had a t 50% = 21 h, close to 24 h 30 ( Supplementary  Fig. 17f) . smURFP initial mean fluorescence shows that membrane permeability is the major factor increasing fluorescence under nonsteady state conditions, but increasing incubation time results in increased protein stability and accumulation of smURFP + chromophore (Supplementary Fig. 17g ).
FP photostability and performance in fusions
smURFP and TDsmURFP show greater photostability than eGFP, mCherry, IFP1.4, and Cy5 in vitro (Supplementary Fig. 18 ). The protein, rather than the BV, governs the photostability, because at an excitation intensity yielding 1,000 photons per s, IFP1.4 + BV bleached with t 50% = 8.4 s, while smURFP + BV had t 50% = 300 s ( Table 1) . Photostability was compared in cells. N-and C-terminal smURFP fusions were created and showed correct cellular localization ( Fig. 4) . smURFP mean t 50% was 340 s and 570 s with BVMe 2 and BV, respectively, in mammalian cells ( Supplementary Fig. 19 ). smURFP + BV photostability is comparable to that of eGFP but greater than that of mCherry and tdTomato ( Supplementary Table 4 ).
An Fr and nir fluorescent cell cycle biosensor
Based on work from Miyawaki and coworkers 4 on the fluorescent ubiquitination-based cell cycle indicator (FUCCI), we created a fluorescent biosensor at wavelengths longer than attainable with jellyfish-or coral-derived FPs using smURFP and IFP2.0 (ref. 18 ). In FUCCI, two spectrally distinct FPs are synthesized and degraded at opposing phases of the cell cycle. Typically a green FP is made during S, G 2 , or M phase and degraded during late M or G 1 phase, while an orange FP is made during G 0 or G 1 phase and destroyed at the start of S phase 4 . smURFP, TDsmURFP, and IFP2.0 were fused to hCdt1(30/120) and hGem(1/110) fragments containing ubiquitination sites for degradation 4 lines were created. smURFP fluorescence was greater than that of TDsmURFP. A stable cell line expressing mAG-hGem(1/110) and smURFP-hCdt1(30/120) was created to verify proper function. smURFP-hCdt1(30/120) showed proper temporal dynamics ( Supplementary Fig. 20 and Supplementary Video 1) . Stably expressing IFP2.0-hGem(1/110) showed sufficient fluorescence, but IFP2.0-hCdt1(30/120) did not. Fluorescence time-lapse imaging verified that HEK293 cells stably expressing smURFP-hCdt1(30/120) and IFP2.0-hGem(1/110) reciprocally lit up during the G 0 or G 1 and S, G 2 , or M phases, respectively ( Fig. 5 and  Supplementary Video 2) . FUCCI now works in the FR and NIR. discussion smURFP is biophysically the brightest FR and NIR FP created, fills a spectral gap in excitation wavelength, expresses efficiently with minimal toxicity, and does not produce hydrogen peroxide.
In addition, unlike its precursor, TeAPCα, smuRFP does not require a lyase to covalently attach its chromophore. smURFP fluorescence is visible without exogenous BV and may be advantageous for imaging cancer or other maladies in vivo, where the production of hydrogen peroxide could alter immune system or inflammation response and/or alter disease progression [9] [10] [11] [12] . Here, it is important to note that previous comparisons of BPH FPs and red FPs in vivo were performed using purified FPs, normalizing concentrations with BV already covalently attached, and by embedding FPs inside phantoms into mice 16, 17 . This experimental setup does not accurately reflect FP expression and accessibility to BV in vivo where, for example, iRFP713 shows little fluorescence when compared to mCardinal 29 .
Membrane permeability of BV is a limiting factor for BPH FPs and smURFP. The development of smURFP fluorescence is controlled by the covalent attachment of the cofactor, not by reversible noncovalent BV affinity. HO-1 expression in neurons increases IFP2.0 fluorescence 18 . HO-1 increased fluorescence significantly for BPH and APCα FPs, and it enhanced more with 5-ALA and iron, which fuel production of heme that HO-1 converts to BV. smURFP and TDsmURFP, unlike BPH FPs, tolerate the freely permeant BVMe 2 . This open chromophore-binding pocket (Fig. 3d) should allow for further modification of tetrapyrroles to modify not only membrane permeability but also spectral and fluorescence properties.
FP photostability is essential for imaging extended time periods or super-resolution. BPH FPs were originally nonfluorescent phototransducers that lacked evolutionary pressure to be light tolerant, whereas APCα is a component of the light-harvesting phycobilisome, which is extremely tolerant of light. Without using a special selection, smURFP is very photostable. Selection for increased photostability should enhance smURFP utility for super-resolution applications.
The FR and NIR FUCCI creates a fluorescent biosensor with wavelengths inaccessible to jellyfish or coral FPs and does not produce hydrogen peroxide. Fluorescently monitoring the cell cycle has identified modifications to cell division, drug-induced cell cycle modification 31 , and quiescent cells 32 . smURFP is brighter than mCardinal in vitro when BVMe 2 is added for 2 d, and it is comparable to eGFP in brightness, which is useful in cell culture for imaging low-copy-number proteins, super-resolution imaging, and biosensors (FRET acceptor or red FP quencher). Despite its strong performance in vitro and modest visibility in vivo, smURFP is not ready for use in mice, as this will require screening new cofactors to achieve maximal brightness. smURFP is the most photostable FP tested in the Tsien lab (all FPs tested by P. Steinbach for over 10 years 3 ). smURFP can be fused to α-tubulin ( Fig. 4d) , one of the most sensitive proteins. In addition, smURFP is one of only three FPs (smURFP, mKO2, and mCherry) known to allow functional fusion to hCdt1(30/120) despite the fact that jellyfish-or coral-derived FPs mAG, eGFP, and mRFP1 are nonfunctional 4 . The FR and NIR FUCCI is the first biosensor using two BV-attaching FPs and can be used with traditional FUCCI to monitor the cell cycle of two cell types.
There are thousands of APCα genes in cyanobacteria and red algae, giving this new class of FPs vast opportunities. Additionally, APCß and other phycobilisome proteins (phycoerythrin and phycocyanin) could be used to create additional FPs. 
online methods
Chemicals. BV and BVMe 2 were purchased from Frontier Scientific. PCB was extracted from Spirulina as described 33 .
Gene synthesis, mutagenesis, and screening of libraries.
TeAPCα gene (codons optimized for Escherichia coli) was made by GenScript. Mutations were placed by random mutagenesis using GeneMorphII Random Mutagenesis Kit (Agilent Technologies). Screens for mutants that fluoresce with PCB or BV were performed by subcloning into a pBAD vector (Life Technologies) that expressed cyanobacteria Synechocystis HO-1 and Synechocystis PcyA genes for PCB production and Synechocystis HO-1 only for BV production, as previously described 34 . Libraries were expressed in TOP10 Electrocompetent Escherichia coli cells (Life Technologies) with addition of 0.2% arabinose to LB agar plates (FPs were constitutively expressed in Escherichia coli). Fluorescence was imaged on plates using a BioSpectrum AC Imaging System (UVP) with EX/EM = 628(40)/690(50) nm for FPs + PCB, EX/EM = 685(40)/710LP nm for rounds 4 and 5 FPs + BV, and EX/EM = 650(13)/690(50) nm for Cy5-like FPs + BV (rounds [6] [7] [8] [9] [10] [11] [12] . At round 6, 5-10 of the brightest colonies on each plate were combined in LB + 0.2% arabinose, grown ~18 h, mixture of plasmid DNA was purified, and TOP10 cells were transformed and plated on LB agar plates + 0.2% arabinose. Fluorescence was screened on plates (as described above), 10-20 of the brightest colonies were screened in liquid culture fluorescence (Supplementary Fig. 2a-e) , plasmid DNA was purified, and DNA was sequenced. The plasmid DNA of 2-3 of the brightest FPs was chosen for mutagenesis for the subsequent round. When choosing DNA for subsequent mutagenesis rounds, genes with increased and/or novel silent DNA mutations were chosen over other DNA that had the same DNA and/or protein sequence of the previous round. Site-specific mutagenesis was performed using QuikChange Lightning Mutagenesis Kit (Agilent Technologies) to create smURFP (C4S mutation) and smURFP C52S.
FP purification and fluorescence characterization in vitro.
FP genes were expressed on a pBAD vector (Life Technologies) with a polyhistidine tag on the C terminus, cells were lysed with B-PER (Thermo Scientific), and purified using Ni-NTA (Qiagen) purification. PCB (HO-1 + PcyA) and BV (HO-1) incorporation in Escherichia coli was performed simultaneously during constitutively active FP expression. Extinction coefficient was determined by PCB or BV absorbance as described 35, 36 ( Table 1) or calculated for the apoproteins by determining the protein concentration by the BCA protein assay (Pierce), and a specific chromophore concentration was added (specified in the Purification of FP lacking chromophore and in vitro chromophore incorporation section) to get 1 and 2 chromophore species (Supplementary Table 3 , not including (Escherichia coli)). When FP chromophore (PCB or BV) was expressed in Escherichia coli, the PCB and BV Q band had absorbance that overlapped with detection of BCA or Bradford assay of 562 nm and 592 nm, respectively. We used the previously published protocols 35, 36 , where there was no change of the BV absorbance at 390 nm when free in solution or attached to the FP. smURFP + BV denaturation with 1 M urea caused no change in the BV absorbance at 390 nm, but the Q band was reduced ~20-fold. Therefore, the extinction coefficient of BV at 390 nm was used to calculate the concentration of holoprotein (FP + PCB or BV) concentration.
EX and EM spectra were obtained using SPEX Fluorolog fluorometer (Horiba). Absorbance spectra were obtained using UV-VIS Spectrophotometer Cary Eclipse (Varian) or UV-2700 (Shimadzu). Quantum yield was determined relative to Cy5. Incorporation rates of BV on 0.5 µM smURFP was performed by addition of smURFP to PBS alone or with 20% fetal bovine serum (FBS) and mixed by pipetting in a quartz cuvette. Chromophore was added last, mixed by pipetting, and fluorescence was recorded using SPEX Fluorolog fluorometer (Horiba). Photobleaching was characterized on bubbles of purified FP or Cy5 within mineral oil using light from a 150 W xenon arc lamp with 100% light through EX/EM = 628(40)/680(30) nm for smURFP, TDsmURFP, and Cy5 or EX/EM = 665(45)/725(50) nm for IFP1.4 focused with a 40×, 1.2 numerical aperture C-Apochromat oil-immersion lens on a Zeiss Axiovert 200M inverted microscope. Photobleaching times were normalized to reflect an initial illumination intensity producing 1,000 photons per fluorescent molecule per second as previously described 37 .
Purification of FP lacking chromophore and in vitro chromophore incorporation. HO-1 was removed by digesting the pBAD vector (Life Technology) with MscI and PmeI (NEB). smURFP and TDsmURFP were expressed and purified as described above.
No chromophore was present on smURFP and TDsmURFP (confirmed by UV, fluorescence imaging, and MS). For predominant fluorescent species + 2 chromophores, a ten-fold excess of chromophore was added to smURFP and TDsmURFP. For predominant fluorescent species + 1 chromophore, a quarter concentration of chromophore was added to smURFP and TDsmURFP. Chromophore was added in PBS + 10% FBS at 37 °C overnight. smURFP + chromophore and TDsmURFP + chromophore were purified using NiNTA (Qiagen) to remove excess or noncovalently attached chromophore.
FP mass spectrometry. FP mass was determined by liquid chromatography-mass spectrometry (LC-MS), where the protein column eluant was directly injected into the electrospray interface of an Orbitrap XL (Thermo Fisher). FP precipitation was minimized by using a steep gradient and injecting column eluant directly into the mass spectrometer. The 1100 LC (Agilent Technologies) had solvent A = 2% acetonitrile (ACN), 0.1% formic acid (FA) and solvent B = 90% ACN, 0.1% FA, the flow rate was 80 µl/min, and the gradient was 18% A to 100% B in 2.4 min. Protein was eluted within 10 min from a 1 mm inner diameter, 50 mm long PLRP-S C18 column (Agilent Technologies). Orbitrap IonSpray (electrospray) interface had a sheath gas flow rate of 34 and T = 275 °C. Capillary was 39 V and the tube lens was 140 V. Full scan mass spectra were collected in the ion trap and Fourier transform profile mode, with Orbitrap resolution 60,000, from 500 to 1,800 mass-to-charge units. Protein mass spectra were deconvolved using either the extract_msn program (Xcalibur software) or with ProMassCalc (ThermoFisher).
Homology model creation, identifying dimeric interface, protein sequence alignment, and creating protein figures. smURFP homology model was created using Swiss-Model Server 38 with Porphyra yezoensis APCα crystal structure (1KN1.pdb 39 npg (http://www.rcsb.org/pdb/explore.do?structureId=1KN1) and sequence in Supplementary Fig. 1) . The homodimeric interface was identified using PatchDock 40 and, subsequently, FireDock 41 . The lowest free-energy structure is shown in Figure 1d . Protein sequence alignments (Supplementary Figs. 1 and 2) were created using ClustalX 42 . All protein figures were created using UCSF Chimera package 43 .
Construction of TDsmURFP bacterial expression vector.
TDsmURFP was created using the smURFP homology model (Fig. 1d) and approximating the distance from the C terminus to the N terminus of the second subunit. A 23-amino-acid linker (GHGTGSTGSGSSGTASSEDNNMA) was sufficient, and primers were created with 5′ BamHI and 3′ EcoRI restriction sites (Integrated DNA Technologies, IDT) smURFP was PCR amplified with Phusion High-Fidelity DNA Polymerase (New England BioLabs, NEB) to create the right and left subunits using 23amino-acid linker primers. The two products were combined, and TDsmURFP was created by bridging PCR with Phusion High-Fidelity DNA Polymerase (NEB). TDsmURFP was digested with BamHI-HF and EcoRI-HF (NEB), gel purified using Zymoclean Gel DNA Recovery Kit (Zymo), and subcloned into a pBAD (Life Technologies) vector containing HO-1 digested with BamHI-HF and EcoRI-HF (NEB) with T4 DNA Ligase (Life Technologies).
Native PAGE, SDS-denaturing PAGE, and zinc blot.
Native PAGE was run using NativePAGE Novex Bis-Tris Gel System (Life Technologies) on NativePAGE 4-16% Bis-Tris protein gels (Life Technologies). SDS-denaturing PAGE was run using NuPAGE MOPS SDS running buffer (Life Technologies) and NuPAGE Novex 4-12% Bis-Tris gels (Life Technologies). Precision Plus Protein Dual Color Standards (Bio-Rad) were used as an MW ladder. Zinc blot was performed after running the SDS-PAGE gel using the described method 44 . Fluorescence was imaged using a BioSpectrum AC Imaging System (UVP) with EX/EM = 535(45)/605(70) nm for tdTomato, EX/EM = 650(13)/690(50) nm for smURFP and TDsmURFP, EX/EM = 685(40)/710LP nm for IFP1.4 and BV + zinc.
Construction of lentiviral vectors, virus production, and neuron infection.
smURFP-T2A-mCherry (GenBank AY678264), smURFP-T2A-mCardinal, smURFP, and mCardinal (Addgene 51311) were subcloned in a generation-two lentiviral vector with the CMV promoter for constitutive expression. Viruses were produced as described 45 
Fluorescence imaging of HT1080 tumor xenografts in vivo.
HT1080 cells were infected with CMV with smURFP-T2A-mCherry, smURFP-T2A-mCardinal, smURFP, and mCardinal lentiviruses in culture, and expression was verified by fluorescence imaging (Supplementary Fig. 14a , ≥99% efficiency and Supplementary Fig. 15a , ≥95% efficiency) using filters described in the previous section. All procedures using mice were approved by UCSD IACUC (#S03172M) and are consistent with the recommendations of the American Veterinary Medical Association. One million HT1080 cells expressing smURFP-T2A-mCherry were injected subcutaneously into the lateral, ventral, and upper right and left quadrant, or smURFP and mCardinal were injected subcutaneously into the lateral, dorsal, and lower right and left quadrant of four 5-week-old athymic nude female mice. Tumors were allowed to grow until ~0.1-1 cm in diameter (~2 weeks). Mice were anesthetized with isoflurane (1.5%) at a 2 liter/min flow, injected with ketamine-midazolam (intraperitoneal (IP), 80 mg/kg, 4 mg/kg), placed on a heated pad, and imaged before exogenous BV injection. 250 nmol BV was injected by intravenous (IV) tail vein, and mice were imaged 5, 30, 60, and 120 min after BV injection for smURFP-T2A-mCherry. 250 nmol BV or BVMe 2 was injected by intravenous tail vein, and mice were imaged 60 min, 24 h, and 48 h after BV injection for smURFP and mCardinal tumors. Mice were imaged using a Maestro in vivo Imaging System (Cambridge Research & Instrumentation, CRI). FPs were imaged with the following filters: mCherry, EX/EM = 590(23)/615LP nm and liquid crystal, 620 nm; mCardinal EX/ EM = 607(36)645LP nm and liquid crystal, 660 nm; and smURFP EX/EM = 620(20)/645LP nm or EX/EM = 640(47)/700LP and liquid crystal, 710 nm. Image cubes were obtained and could be spectrally unmixed, but raw fluorescence images before chromophore injection are shown in Supplementary Figures 14c  and 15f because no fluorescence increase was seen after 250 nmol BV or BVMe 2 injection. Tumors were removed, washed 2× in 2 ml DMEM + 10% FBS, labeled in 2 ml DMEM + 10% FBS + 10 µM BV or BVMe 2 at 4 °C for 24 h, imaged, labeled in 2 ml DMEM + 10% FBS + 10 µM BV or BVMe 2 at 37 °C for 24 h, and imaged (Supplementary Fig. 15g ).
Plasma collection and BV or BVMe 2 concentration analysis.
Whole blood was collected via abdominal aorta and placed in tubes with lithium heparin (BD, No. 365971) on ice. Tubes were centrifuged to remove red blood cells, and plasma was stored on ice for 30 min. Clarified plasma was combined and aliquoted into 9× 70 µl aliquots and placed on ice. The following nine experiments were performed: starting plasma (1) and plasma + 10 µM BV (2-5) or BVMe 2 (6-9) at time 0 at 4 °C and 15, 60, and 1,440 min at 37 °C. Reactions were stopped by freezing at −80 °C. Plasma samples were thawed, diluted 4× with cold 50% ACN, 48% water (H 2 O), and 2% acetic acid, and centrifuged for 14 min at 4 °C. Reverse-phase high performance liquid chromatography (HPLC) was performed on an Agilent 1100 Series HPLC on a Phenomenex Luna C18(2) reverse-phase column 100 Å, 250 cm × 21.20 mm I.D. 10 µm reverse-phase column (00G-4253-P0 AX), with a 21 min, (NEB) with primers containing 5′ HindIII-HF and 3′ XbaI restriction enzyme sites. HindIII-HF and XbaI (NEB)-digested PCR fragments were gel purified (Zymoclean Gel DNA Recovery Kit) and were ligated (T4 DNA Ligase, Life Technologies) into a similarly digested pCDNA3 vector, creating initial pCDNA3-mAG-hGem(1/110) or mKO2-hCdtI(30/120) vectors. smURFP, TDsmURFP, and IFP2.0 were PCR amplified using Phusion High-Fidelity DNA Polymerase (NEB) with primers containing 5′ HindIII and 3′ XhoI, HindIII-HF and XhoI digested (NEB), gel purified (Zymoclean Gel DNA Recovery Kit). pCDNA3 mAG-hGem(1/110) or mKO2-hCdtI(30/120) were digested with HindIII-HF and XhoI (NEB) to remove the FP and linker, dephosphorylated (SAP, Roche), and gel purified (Zymoclean Gel DNA Recovery Kit). pCDNA3 X-hGem(1/110) or hCdtI(30/120) were ligated with smURFP, TDsmURFP, and IFP2.0 to create pCDNA3 smURFP, TDsmURFP, or IFP2.0-hGem(1/110) or hCdtI(30/120), six plasmids with hygromycin B resistance to create stable cell lines.
HEK293A cells were transfected with Lipofectamine 2000 (Life Technologies) on glass-bottom dishes (grown and transfected as described above). Initially, all eight constructs (including mAG-hGem(1/110) and mKO2-hCdtI(30/120)) were fluorescently imaged using a Zeiss Axiovert 200M inverted microscope controlled by SlideBook software. FPs were imaged as follows: mAG EX/EM = 495(10)/535(25) nm, mKO2 EX/EM = 540(25)/595 (50) nm, smURFP or TDsmURFP EX/EX = 628(40)/680(30) nm, and IFP2.0 EX/EM = 665(45)/725(50) nm. smURFP, TDsmURFP, or IFP2.0-hGem(1/110) or hCdtI(30/120) all had fluorescent nuclei when transiently expressed in HEK293A cells. A kill curve was generated with hygromycin B (Life Technologies) and 300 µg/ml hygromycin B was sufficient to kill untransfected HEK293A cells. HEK293A cells expressing mAG or IFP2.0-hGem(1/110) or mKO2 or IFP2.0-hCdtI(30/120) were grown for 3 weeks in growth media + 300 µg/ml hygromycin B. Cells were selected using fluorescently activated cell sorting (FACS) using FACSDiVa (BD Biosciences) to give an enriched stable population containing the expressed FP fusion. Cells expressing FPs were sorted using the following filters: mAG EX/EM = 488/535(20) nm, mKO2 EX/EM = 568/610(40) nm, and IFP2.0 EX/EM = 670/710LP nm. HEK293A cells expressing mAG or IFP2.0-hGem(1/110) were transfected with smURFP or TDsmURFP-hCdtI(30/120), or mKO2 or IFP2.0-hCdtI(30/120) were transfected with smURFP or TDsmURFP-hGem(1/110) and grown for an additional 3 weeks in growth media + 300 µg/ml hygromycin B. 198 individual clones were FACS (smURFP EX/EM = 647(10)/675(20) nm) for the eight combinations and grown for 2 weeks. Clones were initially assayed to verify both FPs and then proper growth (many cells show no growth and/or decreased cell cycle progression, which was typically accompanied by higher FP-fusion expression). TDsmURFP fusions were dimmer than smURFP fusions and were not characterized further. IFP2.0-hCdtI(30/120) or smURFP-hGem(1/110) fluorescence was lacking and/or extremely dim and could not be visualized with smURFP-hGem(1/110) or mKO2-hCdtI(30/120), respectively. mAG-hGem(1/110) + smURFP-hCdtI(30/120) and IFP2.0-hGem(1/110) + smURFP-hCdtI(30/120) (FR and NIR FUCCI) had sufficient fluorescence, and three clones of each were grown and reanalyzed for fluorescence of both FPs and adequate growth. A single clone of each was imaged by time-lapse fluorescence microscopy.
Time-lapse imaging of FUCCI HEK293A cells. HEK293A cells stably expressing FUCCI were grown in growth media on glass-bottom dishes coated with poly-D-lysine. After 2 d, media was changed to 2 ml Leibovitz L-15 medium (no phenol red, Life Technologies) + 1 g/L glucose + 200 µM Trolox + 200 µM L-ascorbic acid + 12.5 µM BV for 1 d. A Zeiss Axiovert 200M inverted microscope with temperature control chamber was allowed to equilibrate at 37 °C for ~30 min and HEK293A FUCCI cell-imaging dish was placed on the stage. The plastic lid was removed and 2.2 ml of mineral oil was added to the top (ensuring complete seal to avoid media evaporation). A metal imaging dish weight sealed with a glass coverslip was placed on top of the imaging chamber to avoid focus drift during imaging. The microscope + dish were equilibrated for ~1 h at 37 °C. Cells were imaged every 15 min using a 10% neutral density filter. FPs were imaged as follows: mAG-hGem(1/110) EX/EM = 488/535 (20) nm, smURFP-hCdtI(30/120) EX/EM = 628(40)/680(30) nm, and IFP2.0-hGem(1/110) EX/EM = 665(45)/725(50) nm. Movies were created in ImageJ 47 . All three image channels (DIC, smURFP-hCdtI(30/120), and mAG or IFP2.0-hGem(1/110)) were opened separately as a hyperstack and brightness and contrast were adjusted as desired. The time was added to the DIC stack using Time Stamper (ImageJ plugin) and the three channels were merged using the following pseudocoloring: red, smURFP-hCdtI(30/120); green, mAG or IFP2.0-hGem(1/110); and gray, DIC. The AVI movie was exported using JPEG compression and ten frames per second in ImageJ. AVI movies were converted to MOV movies using QuickTime Player (Version 10.4, Apple).
Experimental setup, data analysis, and statistical methods.
For cell culture experiments, sample sizes of ≥n = 30 cells (n listed with each experiment) were chosen to ensure P values <0.03 for the majority of significant comparisons. For animal experiments, four mice with two tumors each (n = 8 tumors) were chosen arbitrarily to ensure reproducibility of results. No cell culture dishes or animals were excluded from analysis for any reason. For animal studies, no randomization or blinding was used because both mCherry and smURFP FPs were simultaneously expressed on a bicistronic mRNA in each tumor cell that made up the tumor, or smURFP and mCardinal tumors were imaged simultaneously on the same mouse. Tumors were imaged with both sets of excitation and emission filters. Fluorescence images were adjusted and analyzed using ImageJ 47 . Graphs, statistics, and statistical significance tests were generated using KaleidaGraph 4.1 (Synergy). Comparisons were performed on mean fluorescence intensity with a one-way ANOVA with significance level set at α = 0.05. Equivalence of variance was determined for the one-way ANOVA with a post hoc test of Tukey honestly significant difference (HSD) for comparisons between any two samples. All error bars are s.e.m., except 
